眼科用ドラッグデリバリーシステムのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Ophthalmic Drug Delivery System Market Insights, Forecast to 2028

• レポートコード：QY2207E09907 • 出版社/出版日：QYResearch / 2022年7月 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の眼科用ドラッグデリバリーシステムの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に眼科用ドラッグデリバリーシステムの世界市場のxxx％を占める「埋め込み型眼科用ドラッグデリバリーシステム」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の眼科用ドラッグデリバリーシステムの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの眼科用ドラッグデリバリーシステム市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの眼科用ドラッグデリバリーシステム市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 眼科用ドラッグデリバリーシステムのグローバル主要メーカーには、Aero Pump GmbH、AptarGroup、Bausch Health、Becton Dickinson & Company、EyePoint Pharmaceuticals, Inc.、Gaplast GmbH、Gerresheimer、Nemera、Nipro Corporation、Ocular Therapeutix、Owen Mumford、Silgan Holdings Inc.、Terumo Corporation、West Pharmaceutical Services, Inc.、Kedalion Therapeutics、Re-Vana Therapeutics、Mati Therapeutics, Inc.,、Biocorp Production、Ocumedic, Inc.、Graybug Vision、Taiwan Liposome、Santen Pharmaceutical、Envisia Therapeutics、Clearside Biomedicalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 眼科用ドラッグデリバリーシステム市場は、種類と用途によって区分されます。世界の眼科用ドラッグデリバリーシステム市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 埋め込み型眼科用ドラッグデリバリーシステム、粒子型眼科用ドラッグデリバリーシステム、その他 【用途別セグメント】 病院、クリニック、外来外科センター、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 眼科用ドラッグデリバリーシステム製品概要 - 種類別市場（埋め込み型眼科用ドラッグデリバリーシステム、粒子型眼科用ドラッグデリバリーシステム、その他） - 用途別市場（病院、クリニック、外来外科センター、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の眼科用ドラッグデリバリーシステム販売量予測2017-2028 - 世界の眼科用ドラッグデリバリーシステム売上予測2017-2028 - 眼科用ドラッグデリバリーシステムの地域別販売量 - 眼科用ドラッグデリバリーシステムの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別眼科用ドラッグデリバリーシステム販売量 - 主要メーカー別眼科用ドラッグデリバリーシステム売上 - 主要メーカー別眼科用ドラッグデリバリーシステム価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（埋め込み型眼科用ドラッグデリバリーシステム、粒子型眼科用ドラッグデリバリーシステム、その他） - 眼科用ドラッグデリバリーシステムの種類別販売量 - 眼科用ドラッグデリバリーシステムの種類別売上 - 眼科用ドラッグデリバリーシステムの種類別価格 ・用途別市場規模（病院、クリニック、外来外科センター、その他） - 眼科用ドラッグデリバリーシステムの用途別販売量 - 眼科用ドラッグデリバリーシステムの用途別売上 - 眼科用ドラッグデリバリーシステムの用途別価格 ・北米市場 - 北米の眼科用ドラッグデリバリーシステム市場規模（種類別、用途別） - 主要国別の眼科用ドラッグデリバリーシステム市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの眼科用ドラッグデリバリーシステム市場規模（種類別、用途別） - 主要国別の眼科用ドラッグデリバリーシステム市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の眼科用ドラッグデリバリーシステム市場規模（種類別、用途別） - 主要国別の眼科用ドラッグデリバリーシステム市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の眼科用ドラッグデリバリーシステム市場規模（種類別、用途別） - 主要国別の眼科用ドラッグデリバリーシステム市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの眼科用ドラッグデリバリーシステム市場規模（種類別、用途別） - 主要国別の眼科用ドラッグデリバリーシステム市場規模（トルコ、サウジアラビア） ・企業情報 Aero Pump GmbH、AptarGroup、Bausch Health、Becton Dickinson & Company、EyePoint Pharmaceuticals, Inc.、Gaplast GmbH、Gerresheimer、Nemera、Nipro Corporation、Ocular Therapeutix、Owen Mumford、Silgan Holdings Inc.、Terumo Corporation、West Pharmaceutical Services, Inc.、Kedalion Therapeutics、Re-Vana Therapeutics、Mati Therapeutics, Inc.,、Biocorp Production、Ocumedic, Inc.、Graybug Vision、Taiwan Liposome、Santen Pharmaceutical、Envisia Therapeutics、Clearside Biomedical ・産業チェーン及び販売チャネル分析 - 眼科用ドラッグデリバリーシステムの産業チェーン分析 - 眼科用ドラッグデリバリーシステムの原材料 - 眼科用ドラッグデリバリーシステムの生産プロセス - 眼科用ドラッグデリバリーシステムの販売及びマーケティング - 眼科用ドラッグデリバリーシステムの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 眼科用ドラッグデリバリーシステムの産業動向 - 眼科用ドラッグデリバリーシステムのマーケットドライバー - 眼科用ドラッグデリバリーシステムの課題 - 眼科用ドラッグデリバリーシステムの阻害要因 ・主な調査結果

Market Analysis and Insights: Global Ophthalmic Drug Delivery System Market
Due to the COVID-19 pandemic, the global Ophthalmic Drug Delivery System market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Implantable Ophthalmic Drug Delivery Systems accounting for % of the Ophthalmic Drug Delivery System global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Ophthalmic Drug Delivery System market size is valued at US$ million in 2021, while the US and Europe Ophthalmic Drug Delivery System are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Ophthalmic Drug Delivery System landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Ophthalmic Drug Delivery System include Aero Pump GmbH, AptarGroup, Bausch Health, Becton Dickinson & Company, EyePoint Pharmaceuticals, Inc., Gaplast GmbH, Gerresheimer, Nemera and Nipro Corporation, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Ophthalmic Drug Delivery System Scope and Segment
Ophthalmic Drug Delivery System market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Ophthalmic Drug Delivery System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Implantable Ophthalmic Drug Delivery Systems
Particulate Ophthalmic Drug Delivery Systems
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
By Company
Aero Pump GmbH
AptarGroup
Bausch Health
Becton Dickinson & Company
EyePoint Pharmaceuticals, Inc.
Gaplast GmbH
Gerresheimer
Nemera
Nipro Corporation
Ocular Therapeutix
Owen Mumford
Silgan Holdings Inc.
Terumo Corporation
West Pharmaceutical Services, Inc.
Kedalion Therapeutics
Re-Vana Therapeutics
Mati Therapeutics, Inc.,
Biocorp Production
Ocumedic, Inc.
Graybug Vision
Taiwan Liposome
Santen Pharmaceutical
Envisia Therapeutics
Clearside Biomedical
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

---

1 Study Coverage
1.1 Ophthalmic Drug Delivery System Product Introduction
1.2 Market by Type
1.2.1 Global Ophthalmic Drug Delivery System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Implantable Ophthalmic Drug Delivery Systems
1.2.3 Particulate Ophthalmic Drug Delivery Systems
1.2.4 Others
1.3 Market by Application
1.3.1 Global Ophthalmic Drug Delivery System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Ophthalmic Drug Delivery System Sales Estimates and Forecasts 2017-2028
2.2 Global Ophthalmic Drug Delivery System Revenue Estimates and Forecasts 2017-2028
2.3 Global Ophthalmic Drug Delivery System Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Ophthalmic Drug Delivery System Sales by Region
2.4.1 Global Ophthalmic Drug Delivery System Sales by Region (2017-2022)
2.4.2 Global Sales Ophthalmic Drug Delivery System by Region (2023-2028)
2.5 Global Ophthalmic Drug Delivery System Revenue by Region
2.5.1 Global Ophthalmic Drug Delivery System Revenue by Region (2017-2022)
2.5.2 Global Ophthalmic Drug Delivery System Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Ophthalmic Drug Delivery System Sales by Manufacturers
3.1.1 Global Top Ophthalmic Drug Delivery System Manufacturers by Sales (2017-2022)
3.1.2 Global Ophthalmic Drug Delivery System Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Ophthalmic Drug Delivery System in 2021
3.2 Global Ophthalmic Drug Delivery System Revenue by Manufacturers
3.2.1 Global Ophthalmic Drug Delivery System Revenue by Manufacturers (2017-2022)
3.2.2 Global Ophthalmic Drug Delivery System Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Ophthalmic Drug Delivery System Revenue in 2021
3.3 Global Ophthalmic Drug Delivery System Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Ophthalmic Drug Delivery System Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Ophthalmic Drug Delivery System Sales by Type
4.1.1 Global Ophthalmic Drug Delivery System Historical Sales by Type (2017-2022)
4.1.2 Global Ophthalmic Drug Delivery System Forecasted Sales by Type (2023-2028)
4.1.3 Global Ophthalmic Drug Delivery System Sales Market Share by Type (2017-2028)
4.2 Global Ophthalmic Drug Delivery System Revenue by Type
4.2.1 Global Ophthalmic Drug Delivery System Historical Revenue by Type (2017-2022)
4.2.2 Global Ophthalmic Drug Delivery System Forecasted Revenue by Type (2023-2028)
4.2.3 Global Ophthalmic Drug Delivery System Revenue Market Share by Type (2017-2028)
4.3 Global Ophthalmic Drug Delivery System Price by Type
4.3.1 Global Ophthalmic Drug Delivery System Price by Type (2017-2022)
4.3.2 Global Ophthalmic Drug Delivery System Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Ophthalmic Drug Delivery System Sales by Application
5.1.1 Global Ophthalmic Drug Delivery System Historical Sales by Application (2017-2022)
5.1.2 Global Ophthalmic Drug Delivery System Forecasted Sales by Application (2023-2028)
5.1.3 Global Ophthalmic Drug Delivery System Sales Market Share by Application (2017-2028)
5.2 Global Ophthalmic Drug Delivery System Revenue by Application
5.2.1 Global Ophthalmic Drug Delivery System Historical Revenue by Application (2017-2022)
5.2.2 Global Ophthalmic Drug Delivery System Forecasted Revenue by Application (2023-2028)
5.2.3 Global Ophthalmic Drug Delivery System Revenue Market Share by Application (2017-2028)
5.3 Global Ophthalmic Drug Delivery System Price by Application
5.3.1 Global Ophthalmic Drug Delivery System Price by Application (2017-2022)
5.3.2 Global Ophthalmic Drug Delivery System Price Forecast by Application (2023-2028)
6 North America
6.1 North America Ophthalmic Drug Delivery System Market Size by Type
6.1.1 North America Ophthalmic Drug Delivery System Sales by Type (2017-2028)
6.1.2 North America Ophthalmic Drug Delivery System Revenue by Type (2017-2028)
6.2 North America Ophthalmic Drug Delivery System Market Size by Application
6.2.1 North America Ophthalmic Drug Delivery System Sales by Application (2017-2028)
6.2.2 North America Ophthalmic Drug Delivery System Revenue by Application (2017-2028)
6.3 North America Ophthalmic Drug Delivery System Market Size by Country
6.3.1 North America Ophthalmic Drug Delivery System Sales by Country (2017-2028)
6.3.2 North America Ophthalmic Drug Delivery System Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Ophthalmic Drug Delivery System Market Size by Type
7.1.1 Europe Ophthalmic Drug Delivery System Sales by Type (2017-2028)
7.1.2 Europe Ophthalmic Drug Delivery System Revenue by Type (2017-2028)
7.2 Europe Ophthalmic Drug Delivery System Market Size by Application
7.2.1 Europe Ophthalmic Drug Delivery System Sales by Application (2017-2028)
7.2.2 Europe Ophthalmic Drug Delivery System Revenue by Application (2017-2028)
7.3 Europe Ophthalmic Drug Delivery System Market Size by Country
7.3.1 Europe Ophthalmic Drug Delivery System Sales by Country (2017-2028)
7.3.2 Europe Ophthalmic Drug Delivery System Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Ophthalmic Drug Delivery System Market Size by Type
8.1.1 Asia Pacific Ophthalmic Drug Delivery System Sales by Type (2017-2028)
8.1.2 Asia Pacific Ophthalmic Drug Delivery System Revenue by Type (2017-2028)
8.2 Asia Pacific Ophthalmic Drug Delivery System Market Size by Application
8.2.1 Asia Pacific Ophthalmic Drug Delivery System Sales by Application (2017-2028)
8.2.2 Asia Pacific Ophthalmic Drug Delivery System Revenue by Application (2017-2028)
8.3 Asia Pacific Ophthalmic Drug Delivery System Market Size by Region
8.3.1 Asia Pacific Ophthalmic Drug Delivery System Sales by Region (2017-2028)
8.3.2 Asia Pacific Ophthalmic Drug Delivery System Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Ophthalmic Drug Delivery System Market Size by Type
9.1.1 Latin America Ophthalmic Drug Delivery System Sales by Type (2017-2028)
9.1.2 Latin America Ophthalmic Drug Delivery System Revenue by Type (2017-2028)
9.2 Latin America Ophthalmic Drug Delivery System Market Size by Application
9.2.1 Latin America Ophthalmic Drug Delivery System Sales by Application (2017-2028)
9.2.2 Latin America Ophthalmic Drug Delivery System Revenue by Application (2017-2028)
9.3 Latin America Ophthalmic Drug Delivery System Market Size by Country
9.3.1 Latin America Ophthalmic Drug Delivery System Sales by Country (2017-2028)
9.3.2 Latin America Ophthalmic Drug Delivery System Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Ophthalmic Drug Delivery System Market Size by Type
10.1.1 Middle East and Africa Ophthalmic Drug Delivery System Sales by Type (2017-2028)
10.1.2 Middle East and Africa Ophthalmic Drug Delivery System Revenue by Type (2017-2028)
10.2 Middle East and Africa Ophthalmic Drug Delivery System Market Size by Application
10.2.1 Middle East and Africa Ophthalmic Drug Delivery System Sales by Application (2017-2028)
10.2.2 Middle East and Africa Ophthalmic Drug Delivery System Revenue by Application (2017-2028)
10.3 Middle East and Africa Ophthalmic Drug Delivery System Market Size by Country
10.3.1 Middle East and Africa Ophthalmic Drug Delivery System Sales by Country (2017-2028)
10.3.2 Middle East and Africa Ophthalmic Drug Delivery System Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Aero Pump GmbH
11.1.1 Aero Pump GmbH Corporation Information
11.1.2 Aero Pump GmbH Overview
11.1.3 Aero Pump GmbH Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Aero Pump GmbH Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Aero Pump GmbH Recent Developments
11.2 AptarGroup
11.2.1 AptarGroup Corporation Information
11.2.2 AptarGroup Overview
11.2.3 AptarGroup Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 AptarGroup Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AptarGroup Recent Developments
11.3 Bausch Health
11.3.1 Bausch Health Corporation Information
11.3.2 Bausch Health Overview
11.3.3 Bausch Health Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Bausch Health Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Bausch Health Recent Developments
11.4 Becton Dickinson & Company
11.4.1 Becton Dickinson & Company Corporation Information
11.4.2 Becton Dickinson & Company Overview
11.4.3 Becton Dickinson & Company Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Becton Dickinson & Company Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Becton Dickinson & Company Recent Developments
11.5 EyePoint Pharmaceuticals, Inc.
11.5.1 EyePoint Pharmaceuticals, Inc. Corporation Information
11.5.2 EyePoint Pharmaceuticals, Inc. Overview
11.5.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 EyePoint Pharmaceuticals, Inc. Recent Developments
11.6 Gaplast GmbH
11.6.1 Gaplast GmbH Corporation Information
11.6.2 Gaplast GmbH Overview
11.6.3 Gaplast GmbH Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Gaplast GmbH Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Gaplast GmbH Recent Developments
11.7 Gerresheimer
11.7.1 Gerresheimer Corporation Information
11.7.2 Gerresheimer Overview
11.7.3 Gerresheimer Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Gerresheimer Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Gerresheimer Recent Developments
11.8 Nemera
11.8.1 Nemera Corporation Information
11.8.2 Nemera Overview
11.8.3 Nemera Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Nemera Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Nemera Recent Developments
11.9 Nipro Corporation
11.9.1 Nipro Corporation Corporation Information
11.9.2 Nipro Corporation Overview
11.9.3 Nipro Corporation Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Nipro Corporation Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Nipro Corporation Recent Developments
11.10 Ocular Therapeutix
11.10.1 Ocular Therapeutix Corporation Information
11.10.2 Ocular Therapeutix Overview
11.10.3 Ocular Therapeutix Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Ocular Therapeutix Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Ocular Therapeutix Recent Developments
11.11 Owen Mumford
11.11.1 Owen Mumford Corporation Information
11.11.2 Owen Mumford Overview
11.11.3 Owen Mumford Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Owen Mumford Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Owen Mumford Recent Developments
11.12 Silgan Holdings Inc.
11.12.1 Silgan Holdings Inc. Corporation Information
11.12.2 Silgan Holdings Inc. Overview
11.12.3 Silgan Holdings Inc. Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Silgan Holdings Inc. Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Silgan Holdings Inc. Recent Developments
11.13 Terumo Corporation
11.13.1 Terumo Corporation Corporation Information
11.13.2 Terumo Corporation Overview
11.13.3 Terumo Corporation Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Terumo Corporation Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Terumo Corporation Recent Developments
11.14 West Pharmaceutical Services, Inc.
11.14.1 West Pharmaceutical Services, Inc. Corporation Information
11.14.2 West Pharmaceutical Services, Inc. Overview
11.14.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 West Pharmaceutical Services, Inc. Recent Developments
11.15 Kedalion Therapeutics
11.15.1 Kedalion Therapeutics Corporation Information
11.15.2 Kedalion Therapeutics Overview
11.15.3 Kedalion Therapeutics Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Kedalion Therapeutics Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Kedalion Therapeutics Recent Developments
11.16 Re-Vana Therapeutics
11.16.1 Re-Vana Therapeutics Corporation Information
11.16.2 Re-Vana Therapeutics Overview
11.16.3 Re-Vana Therapeutics Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Re-Vana Therapeutics Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Re-Vana Therapeutics Recent Developments
11.17 Mati Therapeutics, Inc.,
11.17.1 Mati Therapeutics, Inc., Corporation Information
11.17.2 Mati Therapeutics, Inc., Overview
11.17.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Mati Therapeutics, Inc., Recent Developments
11.18 Biocorp Production
11.18.1 Biocorp Production Corporation Information
11.18.2 Biocorp Production Overview
11.18.3 Biocorp Production Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Biocorp Production Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Biocorp Production Recent Developments
11.19 Ocumedic, Inc.
11.19.1 Ocumedic, Inc. Corporation Information
11.19.2 Ocumedic, Inc. Overview
11.19.3 Ocumedic, Inc. Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Ocumedic, Inc. Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Ocumedic, Inc. Recent Developments
11.20 Graybug Vision
11.20.1 Graybug Vision Corporation Information
11.20.2 Graybug Vision Overview
11.20.3 Graybug Vision Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Graybug Vision Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Graybug Vision Recent Developments
11.21 Taiwan Liposome
11.21.1 Taiwan Liposome Corporation Information
11.21.2 Taiwan Liposome Overview
11.21.3 Taiwan Liposome Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Taiwan Liposome Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Taiwan Liposome Recent Developments
11.22 Santen Pharmaceutical
11.22.1 Santen Pharmaceutical Corporation Information
11.22.2 Santen Pharmaceutical Overview
11.22.3 Santen Pharmaceutical Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 Santen Pharmaceutical Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 Santen Pharmaceutical Recent Developments
11.23 Envisia Therapeutics
11.23.1 Envisia Therapeutics Corporation Information
11.23.2 Envisia Therapeutics Overview
11.23.3 Envisia Therapeutics Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.23.4 Envisia Therapeutics Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.23.5 Envisia Therapeutics Recent Developments
11.24 Clearside Biomedical
11.24.1 Clearside Biomedical Corporation Information
11.24.2 Clearside Biomedical Overview
11.24.3 Clearside Biomedical Ophthalmic Drug Delivery System Sales, Price, Revenue and Gross Margin (2017-2022)
11.24.4 Clearside Biomedical Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
11.24.5 Clearside Biomedical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Ophthalmic Drug Delivery System Industry Chain Analysis
12.2 Ophthalmic Drug Delivery System Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Ophthalmic Drug Delivery System Production Mode & Process
12.4 Ophthalmic Drug Delivery System Sales and Marketing
12.4.1 Ophthalmic Drug Delivery System Sales Channels
12.4.2 Ophthalmic Drug Delivery System Distributors
12.5 Ophthalmic Drug Delivery System Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Ophthalmic Drug Delivery System Industry Trends
13.2 Ophthalmic Drug Delivery System Market Drivers
13.3 Ophthalmic Drug Delivery System Market Challenges
13.4 Ophthalmic Drug Delivery System Market Restraints
14 Key Findings in The Global Ophthalmic Drug Delivery System Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Ophthalmic Drug Delivery System Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Implantable Ophthalmic Drug Delivery Systems
Table 3. Major Manufacturers of Particulate Ophthalmic Drug Delivery Systems
Table 4. Major Manufacturers of Others
Table 5. Global Ophthalmic Drug Delivery System Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Ophthalmic Drug Delivery System Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Ophthalmic Drug Delivery System Sales by Region (2017-2022) & (K Units)
Table 8. Global Ophthalmic Drug Delivery System Sales Market Share by Region (2017-2022)
Table 9. Global Ophthalmic Drug Delivery System Sales by Region (2023-2028) & (K Units)
Table 10. Global Ophthalmic Drug Delivery System Sales Market Share by Region (2023-2028)
Table 11. Global Ophthalmic Drug Delivery System Revenue by Region (2017-2022) & (US$ Million)
Table 12. Global Ophthalmic Drug Delivery System Revenue Market Share by Region (2017-2022)
Table 13. Global Ophthalmic Drug Delivery System Revenue by Region (2023-2028) & (US$ Million)
Table 14. Global Ophthalmic Drug Delivery System Revenue Market Share by Region (2023-2028)
Table 15. Global Ophthalmic Drug Delivery System Sales by Manufacturers (2017-2022) & (K Units)
Table 16. Global Ophthalmic Drug Delivery System Sales Share by Manufacturers (2017-2022)
Table 17. Global Ophthalmic Drug Delivery System Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 18. Global Ophthalmic Drug Delivery System Revenue Share by Manufacturers (2017-2022)
Table 19. Ophthalmic Drug Delivery System Price by Manufacturers (2017-2022) &(US$/Unit)
Table 20. Global Ophthalmic Drug Delivery System Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 21. Global Ophthalmic Drug Delivery System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ophthalmic Drug Delivery System as of 2021)
Table 22. Ophthalmic Drug Delivery System Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Ophthalmic Drug Delivery System Product Offered
Table 24. Date of Manufacturers Enter into Ophthalmic Drug Delivery System Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Ophthalmic Drug Delivery System Sales by Type (2017-2022) & (K Units)
Table 27. Global Ophthalmic Drug Delivery System Sales by Type (2023-2028) & (K Units)
Table 28. Global Ophthalmic Drug Delivery System Sales Share by Type (2017-2022)
Table 29. Global Ophthalmic Drug Delivery System Sales Share by Type (2023-2028)
Table 30. Global Ophthalmic Drug Delivery System Revenue by Type (2017-2022) & (US$ Million)
Table 31. Global Ophthalmic Drug Delivery System Revenue by Type (2023-2028) & (US$ Million)
Table 32. Global Ophthalmic Drug Delivery System Revenue Share by Type (2017-2022)
Table 33. Global Ophthalmic Drug Delivery System Revenue Share by Type (2023-2028)
Table 34. Ophthalmic Drug Delivery System Price by Type (2017-2022) & (US$/Unit)
Table 35. Global Ophthalmic Drug Delivery System Price Forecast by Type (2023-2028) & (US$/Unit)
Table 36. Global Ophthalmic Drug Delivery System Sales by Application (2017-2022) & (K Units)
Table 37. Global Ophthalmic Drug Delivery System Sales by Application (2023-2028) & (K Units)
Table 38. Global Ophthalmic Drug Delivery System Sales Share by Application (2017-2022)
Table 39. Global Ophthalmic Drug Delivery System Sales Share by Application (2023-2028)
Table 40. Global Ophthalmic Drug Delivery System Revenue by Application (2017-2022) & (US$ Million)
Table 41. Global Ophthalmic Drug Delivery System Revenue by Application (2023-2028) & (US$ Million)
Table 42. Global Ophthalmic Drug Delivery System Revenue Share by Application (2017-2022)
Table 43. Global Ophthalmic Drug Delivery System Revenue Share by Application (2023-2028)
Table 44. Ophthalmic Drug Delivery System Price by Application (2017-2022) & (US$/Unit)
Table 45. Global Ophthalmic Drug Delivery System Price Forecast by Application (2023-2028) & (US$/Unit)
Table 46. North America Ophthalmic Drug Delivery System Sales by Type (2017-2022) & (K Units)
Table 47. North America Ophthalmic Drug Delivery System Sales by Type (2023-2028) & (K Units)
Table 48. North America Ophthalmic Drug Delivery System Revenue by Type (2017-2022) & (US$ Million)
Table 49. North America Ophthalmic Drug Delivery System Revenue by Type (2023-2028) & (US$ Million)
Table 50. North America Ophthalmic Drug Delivery System Sales by Application (2017-2022) & (K Units)
Table 51. North America Ophthalmic Drug Delivery System Sales by Application (2023-2028) & (K Units)
Table 52. North America Ophthalmic Drug Delivery System Revenue by Application (2017-2022) & (US$ Million)
Table 53. North America Ophthalmic Drug Delivery System Revenue by Application (2023-2028) & (US$ Million)
Table 54. North America Ophthalmic Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 55. North America Ophthalmic Drug Delivery System Sales by Country (2023-2028) & (K Units)
Table 56. North America Ophthalmic Drug Delivery System Revenue by Country (2017-2022) & (US$ Million)
Table 57. North America Ophthalmic Drug Delivery System Revenue by Country (2023-2028) & (US$ Million)
Table 58. Europe Ophthalmic Drug Delivery System Sales by Type (2017-2022) & (K Units)
Table 59. Europe Ophthalmic Drug Delivery System Sales by Type (2023-2028) & (K Units)
Table 60. Europe Ophthalmic Drug Delivery System Revenue by Type (2017-2022) & (US$ Million)
Table 61. Europe Ophthalmic Drug Delivery System Revenue by Type (2023-2028) & (US$ Million)
Table 62. Europe Ophthalmic Drug Delivery System Sales by Application (2017-2022) & (K Units)
Table 63. Europe Ophthalmic Drug Delivery System Sales by Application (2023-2028) & (K Units)
Table 64. Europe Ophthalmic Drug Delivery System Revenue by Application (2017-2022) & (US$ Million)
Table 65. Europe Ophthalmic Drug Delivery System Revenue by Application (2023-2028) & (US$ Million)
Table 66. Europe Ophthalmic Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 67. Europe Ophthalmic Drug Delivery System Sales by Country (2023-2028) & (K Units)
Table 68. Europe Ophthalmic Drug Delivery System Revenue by Country (2017-2022) & (US$ Million)
Table 69. Europe Ophthalmic Drug Delivery System Revenue by Country (2023-2028) & (US$ Million)
Table 70. Asia Pacific Ophthalmic Drug Delivery System Sales by Type (2017-2022) & (K Units)
Table 71. Asia Pacific Ophthalmic Drug Delivery System Sales by Type (2023-2028) & (K Units)
Table 72. Asia Pacific Ophthalmic Drug Delivery System Revenue by Type (2017-2022) & (US$ Million)
Table 73. Asia Pacific Ophthalmic Drug Delivery System Revenue by Type (2023-2028) & (US$ Million)
Table 74. Asia Pacific Ophthalmic Drug Delivery System Sales by Application (2017-2022) & (K Units)
Table 75. Asia Pacific Ophthalmic Drug Delivery System Sales by Application (2023-2028) & (K Units)
Table 76. Asia Pacific Ophthalmic Drug Delivery System Revenue by Application (2017-2022) & (US$ Million)
Table 77. Asia Pacific Ophthalmic Drug Delivery System Revenue by Application (2023-2028) & (US$ Million)
Table 78. Asia Pacific Ophthalmic Drug Delivery System Sales by Region (2017-2022) & (K Units)
Table 79. Asia Pacific Ophthalmic Drug Delivery System Sales by Region (2023-2028) & (K Units)
Table 80. Asia Pacific Ophthalmic Drug Delivery System Revenue by Region (2017-2022) & (US$ Million)
Table 81. Asia Pacific Ophthalmic Drug Delivery System Revenue by Region (2023-2028) & (US$ Million)
Table 82. Latin America Ophthalmic Drug Delivery System Sales by Type (2017-2022) & (K Units)
Table 83. Latin America Ophthalmic Drug Delivery System Sales by Type (2023-2028) & (K Units)
Table 84. Latin America Ophthalmic Drug Delivery System Revenue by Type (2017-2022) & (US$ Million)
Table 85. Latin America Ophthalmic Drug Delivery System Revenue by Type (2023-2028) & (US$ Million)
Table 86. Latin America Ophthalmic Drug Delivery System Sales by Application (2017-2022) & (K Units)
Table 87. Latin America Ophthalmic Drug Delivery System Sales by Application (2023-2028) & (K Units)
Table 88. Latin America Ophthalmic Drug Delivery System Revenue by Application (2017-2022) & (US$ Million)
Table 89. Latin America Ophthalmic Drug Delivery System Revenue by Application (2023-2028) & (US$ Million)
Table 90. Latin America Ophthalmic Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 91. Latin America Ophthalmic Drug Delivery System Sales by Country (2023-2028) & (K Units)
Table 92. Latin America Ophthalmic Drug Delivery System Revenue by Country (2017-2022) & (US$ Million)
Table 93. Latin America Ophthalmic Drug Delivery System Revenue by Country (2023-2028) & (US$ Million)
Table 94. Middle East and Africa Ophthalmic Drug Delivery System Sales by Type (2017-2022) & (K Units)
Table 95. Middle East and Africa Ophthalmic Drug Delivery System Sales by Type (2023-2028) & (K Units)
Table 96. Middle East and Africa Ophthalmic Drug Delivery System Revenue by Type (2017-2022) & (US$ Million)
Table 97. Middle East and Africa Ophthalmic Drug Delivery System Revenue by Type (2023-2028) & (US$ Million)
Table 98. Middle East and Africa Ophthalmic Drug Delivery System Sales by Application (2017-2022) & (K Units)
Table 99. Middle East and Africa Ophthalmic Drug Delivery System Sales by Application (2023-2028) & (K Units)
Table 100. Middle East and Africa Ophthalmic Drug Delivery System Revenue by Application (2017-2022) & (US$ Million)
Table 101. Middle East and Africa Ophthalmic Drug Delivery System Revenue by Application (2023-2028) & (US$ Million)
Table 102. Middle East and Africa Ophthalmic Drug Delivery System Sales by Country (2017-2022) & (K Units)
Table 103. Middle East and Africa Ophthalmic Drug Delivery System Sales by Country (2023-2028) & (K Units)
Table 104. Middle East and Africa Ophthalmic Drug Delivery System Revenue by Country (2017-2022) & (US$ Million)
Table 105. Middle East and Africa Ophthalmic Drug Delivery System Revenue by Country (2023-2028) & (US$ Million)
Table 106. Aero Pump GmbH Corporation Information
Table 107. Aero Pump GmbH Description and Major Businesses
Table 108. Aero Pump GmbH Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 109. Aero Pump GmbH Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 110. Aero Pump GmbH Recent Developments
Table 111. AptarGroup Corporation Information
Table 112. AptarGroup Description and Major Businesses
Table 113. AptarGroup Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 114. AptarGroup Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 115. AptarGroup Recent Developments
Table 116. Bausch Health Corporation Information
Table 117. Bausch Health Description and Major Businesses
Table 118. Bausch Health Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 119. Bausch Health Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 120. Bausch Health Recent Developments
Table 121. Becton Dickinson & Company Corporation Information
Table 122. Becton Dickinson & Company Description and Major Businesses
Table 123. Becton Dickinson & Company Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 124. Becton Dickinson & Company Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 125. Becton Dickinson & Company Recent Developments
Table 126. EyePoint Pharmaceuticals, Inc. Corporation Information
Table 127. EyePoint Pharmaceuticals, Inc. Description and Major Businesses
Table 128. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 129. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 130. EyePoint Pharmaceuticals, Inc. Recent Developments
Table 131. Gaplast GmbH Corporation Information
Table 132. Gaplast GmbH Description and Major Businesses
Table 133. Gaplast GmbH Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 134. Gaplast GmbH Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 135. Gaplast GmbH Recent Developments
Table 136. Gerresheimer Corporation Information
Table 137. Gerresheimer Description and Major Businesses
Table 138. Gerresheimer Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 139. Gerresheimer Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 140. Gerresheimer Recent Developments
Table 141. Nemera Corporation Information
Table 142. Nemera Description and Major Businesses
Table 143. Nemera Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 144. Nemera Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 145. Nemera Recent Developments
Table 146. Nipro Corporation Corporation Information
Table 147. Nipro Corporation Description and Major Businesses
Table 148. Nipro Corporation Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 149. Nipro Corporation Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 150. Nipro Corporation Recent Developments
Table 151. Ocular Therapeutix Corporation Information
Table 152. Ocular Therapeutix Description and Major Businesses
Table 153. Ocular Therapeutix Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 154. Ocular Therapeutix Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 155. Ocular Therapeutix Recent Developments
Table 156. Owen Mumford Corporation Information
Table 157. Owen Mumford Description and Major Businesses
Table 158. Owen Mumford Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 159. Owen Mumford Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 160. Owen Mumford Recent Developments
Table 161. Silgan Holdings Inc. Corporation Information
Table 162. Silgan Holdings Inc. Description and Major Businesses
Table 163. Silgan Holdings Inc. Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 164. Silgan Holdings Inc. Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 165. Silgan Holdings Inc. Recent Developments
Table 166. Terumo Corporation Corporation Information
Table 167. Terumo Corporation Description and Major Businesses
Table 168. Terumo Corporation Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 169. Terumo Corporation Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 170. Terumo Corporation Recent Developments
Table 171. West Pharmaceutical Services, Inc. Corporation Information
Table 172. West Pharmaceutical Services, Inc. Description and Major Businesses
Table 173. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 174. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 175. West Pharmaceutical Services, Inc. Recent Developments
Table 176. Kedalion Therapeutics Corporation Information
Table 177. Kedalion Therapeutics Description and Major Businesses
Table 178. Kedalion Therapeutics Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 179. Kedalion Therapeutics Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 180. Kedalion Therapeutics Recent Developments
Table 181. Re-Vana Therapeutics Corporation Information
Table 182. Re-Vana Therapeutics Description and Major Businesses
Table 183. Re-Vana Therapeutics Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 184. Re-Vana Therapeutics Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 185. Re-Vana Therapeutics Recent Developments
Table 186. Mati Therapeutics, Inc., Corporation Information
Table 187. Mati Therapeutics, Inc., Description and Major Businesses
Table 188. Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 189. Mati Therapeutics, Inc., Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 190. Mati Therapeutics, Inc., Recent Developments
Table 191. Biocorp Production Corporation Information
Table 192. Biocorp Production Description and Major Businesses
Table 193. Biocorp Production Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 194. Biocorp Production Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 195. Biocorp Production Recent Developments
Table 196. Ocumedic, Inc. Corporation Information
Table 197. Ocumedic, Inc. Description and Major Businesses
Table 198. Ocumedic, Inc. Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 199. Ocumedic, Inc. Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 200. Ocumedic, Inc. Recent Developments
Table 201. Graybug Vision Corporation Information
Table 202. Graybug Vision Description and Major Businesses
Table 203. Graybug Vision Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 204. Graybug Vision Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 205. Graybug Vision Recent Developments
Table 206. Taiwan Liposome Corporation Information
Table 207. Taiwan Liposome Description and Major Businesses
Table 208. Taiwan Liposome Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 209. Taiwan Liposome Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 210. Taiwan Liposome Recent Developments
Table 211. Santen Pharmaceutical Corporation Information
Table 212. Santen Pharmaceutical Description and Major Businesses
Table 213. Santen Pharmaceutical Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 214. Santen Pharmaceutical Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 215. Santen Pharmaceutical Recent Developments
Table 216. Envisia Therapeutics Corporation Information
Table 217. Envisia Therapeutics Description and Major Businesses
Table 218. Envisia Therapeutics Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 219. Envisia Therapeutics Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 220. Envisia Therapeutics Recent Developments
Table 221. Clearside Biomedical Corporation Information
Table 222. Clearside Biomedical Description and Major Businesses
Table 223. Clearside Biomedical Ophthalmic Drug Delivery System Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 224. Clearside Biomedical Ophthalmic Drug Delivery System Product Model Numbers, Pictures, Descriptions and Specifications
Table 225. Clearside Biomedical Recent Developments
Table 226. Key Raw Materials Lists
Table 227. Raw Materials Key Suppliers Lists
Table 228. Ophthalmic Drug Delivery System Distributors List
Table 229. Ophthalmic Drug Delivery System Customers List
Table 230. Ophthalmic Drug Delivery System Market Trends
Table 231. Ophthalmic Drug Delivery System Market Drivers
Table 232. Ophthalmic Drug Delivery System Market Challenges
Table 233. Ophthalmic Drug Delivery System Market Restraints
Table 234. Research Programs/Design for This Report
Table 235. Key Data Information from Secondary Sources
Table 236. Key Data Information from Primary Sources
List of Figures
Figure 1. Ophthalmic Drug Delivery System Product Picture
Figure 3. Global Ophthalmic Drug Delivery System Market Share by Type in 2021 & 2028
Figure 3. Implantable Ophthalmic Drug Delivery Systems Product Picture
Figure 4. Particulate Ophthalmic Drug Delivery Systems Product Picture
Figure 5. Others Product Picture
Figure 6. Global Ophthalmic Drug Delivery System Market Share by Application in 2021 & 2028
Figure 7. Hospitals
Figure 8. Clinics
Figure 9. Ambulatory Surgical Centers
Figure 10. Others
Figure 11. Ophthalmic Drug Delivery System Report Years Considered
Figure 12. Global Ophthalmic Drug Delivery System Sales 2017-2028 (K Units)
Figure 13. Global Ophthalmic Drug Delivery System Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Ophthalmic Drug Delivery System Revenue 2017-2028 (US$ Million)
Figure 15. Global Ophthalmic Drug Delivery System Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Ophthalmic Drug Delivery System Sales Market Share by Region (2017-2022)
Figure 17. Global Ophthalmic Drug Delivery System Sales Market Share by Region (2023-2028)
Figure 18. North America Ophthalmic Drug Delivery System Sales YoY (2017-2028) & (K Units)
Figure 19. North America Ophthalmic Drug Delivery System Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Ophthalmic Drug Delivery System Sales YoY (2017-2028) & (K Units)
Figure 21. Europe Ophthalmic Drug Delivery System Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Ophthalmic Drug Delivery System Sales YoY (2017-2028) & (K Units)
Figure 23. Asia-Pacific Ophthalmic Drug Delivery System Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Ophthalmic Drug Delivery System Sales YoY (2017-2028) & (K Units)
Figure 25. Latin America Ophthalmic Drug Delivery System Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Ophthalmic Drug Delivery System Sales YoY (2017-2028) & (K Units)
Figure 27. Middle East & Africa Ophthalmic Drug Delivery System Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Ophthalmic Drug Delivery System Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Ophthalmic Drug Delivery System in the World: Market Share by Ophthalmic Drug Delivery System Revenue in 2021
Figure 30. Global Ophthalmic Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Ophthalmic Drug Delivery System Sales Market Share by Type (2017-2028)
Figure 32. Global Ophthalmic Drug Delivery System Revenue Market Share by Type (2017-2028)
Figure 33. Global Ophthalmic Drug Delivery System Sales Market Share by Application (2017-2028)
Figure 34. Global Ophthalmic Drug Delivery System Revenue Market Share by Application (2017-2028)
Figure 35. North America Ophthalmic Drug Delivery System Sales Market Share by Type (2017-2028)
Figure 36. North America Ophthalmic Drug Delivery System Revenue Market Share by Type (2017-2028)
Figure 37. North America Ophthalmic Drug Delivery System Sales Market Share by Application (2017-2028)
Figure 38. North America Ophthalmic Drug Delivery System Revenue Market Share by Application (2017-2028)
Figure 39. North America Ophthalmic Drug Delivery System Sales Share by Country (2017-2028)
Figure 40. North America Ophthalmic Drug Delivery System Revenue Share by Country (2017-2028)
Figure 41. United States Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Ophthalmic Drug Delivery System Sales Market Share by Type (2017-2028)
Figure 44. Europe Ophthalmic Drug Delivery System Revenue Market Share by Type (2017-2028)
Figure 45. Europe Ophthalmic Drug Delivery System Sales Market Share by Application (2017-2028)
Figure 46. Europe Ophthalmic Drug Delivery System Revenue Market Share by Application (2017-2028)
Figure 47. Europe Ophthalmic Drug Delivery System Sales Share by Country (2017-2028)
Figure 48. Europe Ophthalmic Drug Delivery System Revenue Share by Country (2017-2028)
Figure 49. Germany Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 50. France Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Ophthalmic Drug Delivery System Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Ophthalmic Drug Delivery System Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Ophthalmic Drug Delivery System Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Ophthalmic Drug Delivery System Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Ophthalmic Drug Delivery System Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Ophthalmic Drug Delivery System Revenue Share by Region (2017-2028)
Figure 60. China Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 63. India Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Ophthalmic Drug Delivery System Sales Market Share by Type (2017-2028)
Figure 70. Latin America Ophthalmic Drug Delivery System Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Ophthalmic Drug Delivery System Sales Market Share by Application (2017-2028)
Figure 72. Latin America Ophthalmic Drug Delivery System Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Ophthalmic Drug Delivery System Sales Share by Country (2017-2028)
Figure 74. Latin America Ophthalmic Drug Delivery System Revenue Share by Country (2017-2028)
Figure 75. Mexico Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 78. Middle East and Africa Ophthalmic Drug Delivery System Sales Market Share by Type (2017-2028)
Figure 79. Middle East and Africa Ophthalmic Drug Delivery System Revenue Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Ophthalmic Drug Delivery System Sales Market Share by Application (2017-2028)
Figure 81. Middle East and Africa Ophthalmic Drug Delivery System Revenue Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Ophthalmic Drug Delivery System Sales Share by Country (2017-2028)
Figure 83. Middle East and Africa Ophthalmic Drug Delivery System Revenue Share by Country (2017-2028)
Figure 84. Turkey Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 85. Saudi Arabia Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 86. UAE Ophthalmic Drug Delivery System Revenue (2017-2028) & (US$ Million)
Figure 87. Ophthalmic Drug Delivery System Value Chain
Figure 88. Ophthalmic Drug Delivery System Production Process
Figure 8

---